Strategic siRNA Screening Approaches to Target Cancer at the Cancer Research UK Beatson Institute

Author(s): Emma J. Shanks

Journal Name: Combinatorial Chemistry & High Throughput Screening
Accelerated Technologies for Biotechnology, Bioassays, Medicinal Chemistry and Natural Products Research

Volume 17 , Issue 4 , 2014

Become EABM
Become Reviewer


The RNAi Screening Facility at the Cancer Research UK Beatson Institute combines siRNA genome-wide screening with drug screening coupled with High Content Imaging and fluorescence-based phenotypic assays to target multiple types of cancer. Here, we describe the infrastructure of the Facility and the approaches we utilise. We also share our experiences in running such a facility and developing and executing screening campaigns, with particular regard to high content multiparametric analysis, data management and statistical analysis.

Keywords: Cancer, high content analysis, phenotypic screening, RNAi screening, statistical analysis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [328 - 332]
Pages: 5
DOI: 10.2174/1386207317666140323133249
Price: $65

Article Metrics

PDF: 39